FDA Requests Comments on Proposed Collection of Information for Fast Track Drug Development Programs

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to fast track drug development programs, which have been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.